Company profile: Corlieve Therapeutics
1.1 - Company Overview
Company description
- Provider of novel therapeutic options for patients with severe neurological disorders.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Corlieve Therapeutics
Patch Biosciences
HQ: United States
Website
- Description: Provider of machine-designed DNA and an AI platform for sequence design to engineer more effective and durable gene therapies, leveraging large-scale DNA synthesis and machine learning. Offers synthetic promoter and untranslated region engineering, validated muscle promoters, and robust RNA UTRs for genetic and RNA-based medicines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Patch Biosciences company profile →
Psomagen
HQ: United States
Website
- Description: Provider of genomics services for research, clinical, and direct-to-consumer applications, including whole genome sequencing, targeted sequencing, Illumina-compatible library runs as flow cell or lane units with full quality control and sample multiplexing, and genetic testing panels to identify gene, chromosome, or protein changes to help confirm or rule out genetic conditions and assess disease risk.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Psomagen company profile →
GeneTether
HQ: United States
Website
- Description: Provider of genome editing enhancement platforms that tether or conjugate donor DNA templates to editing complexes, including the GeneTether Platform and TNT technology to boost DNA insertion efficiency with targeted tools like CRISPR-Cas, and pursuing strategic partnerships in human therapeutics, animal health, agriculture, and cell delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GeneTether company profile →
Genomatix
HQ: Germany
Website
- Description: Provider of computational biology software, databases, and services for understanding gene regulation at the molecular level, including sequence analysis, functional promoter analysis, proprietary genome annotation, and promoter sequence databases, plus testing and interpreting genomic data, representing a central part of systems biology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genomatix company profile →
Tute Genomics
HQ: United States
Website
- Description: Provider of a cloud-based clinical genome interpretation platform that rapidly analyzes and annotates personal genomes, enabling researchers and clinicians to utilize human genome data for scientific discovery and individualized treatment, incorporating proprietary machine-learning algorithms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tute Genomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Corlieve Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Corlieve Therapeutics
2.2 - Growth funds investing in similar companies to Corlieve Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Corlieve Therapeutics
4.2 - Public trading comparable groups for Corlieve Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →